Biostimulants Application to Lettuce (SwE4WEEKS)

October 22, 2024 updated by: Sara Baldassano, University of Palermo

Biostimulants Application to Vegetables

Biostimulants application to vegetables is a useful agronomic approach to reduce the use of pesticides and to improve crop yield and quality by a naturally functionalizing process. The aim of the study is to verify the effects of a nutritional intervention with lettuce Biostimulated by application of seaweed extracts derived from Ecklonia maxima (SwE) in a healthy population in order to assess influence on specific essential minerals like calcium, potassium iron, magnesium, phosphorous (Primary outcome) and metabolisms like glucose, lipid, iron homeostasis (Secondary outcome).

Study Overview

Detailed Description

The present project aims to investigate the benefits of biostimulants lettuce in a cohort of healthy individuals. Biostimulants are organic and inorganic compounds or microorganisms that when applied to plants can enhance plants' growth, yield, and tolerance to stress. Seaweed extract treatment seems to enhance mineral concentration in crops. Participants will be fed with biostimulated lettuce or a tablet of iron daily in order to study the influence on hematological parameters.

A cohort of healthy subjects will be divided into a control group, receiving control lettuce, lettuce SwE group, receiving biostimulated lettuce and iron tablet group receiving iron bisglycinate (30 mg) supplement in tablet for a total of 4 weeks. Blood samples will be collected in specific tubes before (baseline) and after the nutritional intervention (T2). The group will eat 100 grams of Lettuce (control group) and 100 grams of SwE Biostimulated lettuce (intervention group lettuce) for 4 weeks (100 grams/daily) or a tablet of iron (intervention group iron tablet) and collect blood samples (serum and plasma) baseline, before starting the nutritional intervention and after 4 weeks (T2).

Each subject will be subjected to two venous blood samples taken at the beginning of the observation and at the end. The samples obtained will be transported in certified containers for the safe transport of biological samples, and, subsequently, processed by the experimenters at the laboratories of the Molecular Biology section of the University of Palermo. Serum and plasma will be obtained from each blood sample. All information thus obtained will be recorded in a database in which each person will be identified with a numerical code, in order to comply with current privacy regulations. Body weight, Barefoot standing height, Body mass index, Body composition will be measured in the different groups of study. Samples will be analyzed and compared for glucose, insulin, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, Ferritin, Iron, transferrin, Magnesium, Calcium, Potassium, Phosphate, Potassium.

Statistical analysis plan:

Student t tests will be used to compare the baseline characteristics of the groups. Changes between baseline and follow-up will be analyzed by one-way ANOVA followed by Sidak post test. A P < 0.05 will be considered to be statistically significant by using appropriate software.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Palermo, Italy, 90128
        • NABbio, STEBICEF department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 20 - 70 years
  • Italian Ethnicity
  • Body mass index between 18.5 and 28.5 kg/m2
  • Clinically Healthy

Exclusion Criteria:

  • Chronic disease
  • Use of drugs
  • Pregnancy
  • Exogenous hormones
  • Breastfeeding
  • Use of supplements
  • sensitivity to lettuce

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The control group received lettuce (control lettuce 100 grams/day) that was without any biostimulation with Ecklonia Maxima algae but with the same characteristic of SwE lettuce (soil, water, harvesting time) for 4 weeks.
Experimental: Biostimulated SwE lettuce intervention group
The SwE lettuce intervention group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) for 4 weeks
the intervention group SwE lettuce group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) daily for 4 weeks
Experimental: Iron tablet intervention group
The iron tablet intervention group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks
The iron tablet group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of minerals concentration in participants
Time Frame: 4 weeks
Calcium (mg/dL), Phosphate (mg/dL), Magnesium (mg/dL) will be assessed in serum at baseline and after 4 weeks.
4 weeks
Measurement of iron concentration in participants
Time Frame: 4 weeks
Iron (μg/dL) will be assessed in serum at baseline and after 4 weeks.
4 weeks
Measurement of Potassium concentration in participants
Time Frame: 4 weeks
Potassium (mmol/L) will be assessed in serum at baseline and after 4 weeks.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of ferritin in participants
Time Frame: 4 weeks
Ferritin (ng/dL) will be measured in serum at baseline and after 4 weeks
4 weeks
Measurement of lipid metabolism markers in participants
Time Frame: 4 weeks
triglicerises, HDL, LDL, cholesterol (in mg/dL) will be measured in serum at baseline and after 4 weeks
4 weeks
Measurement of insulin in participants
Time Frame: 4 weeks
insulin (mUI/L) will be measured in serum at baseline and after 4 weeks
4 weeks
Measurement of transferrin in participants
Time Frame: 4 weeks
transferrin (mg/dL) will be measured in serum at baseline and after 4 weeks
4 weeks
Measurement of % saturation of transferrin in participants
Time Frame: 4 weeks
% saturation of transferrin will be measured in serum at baseline and after 4 weeks
4 weeks
Measurement of glucose in participants
Time Frame: 4 weeks
glucose (mg/dL) will be measured in serum at baseline and after 4 weeks
4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of Height in participants
Time Frame: 4 weeks
Height (meters) will be assessed at baseline and after 4 weeks
4 weeks
Measurement of body mass index (BMI) in participants
Time Frame: 4 weeks
weight in kilograms, height in meters will be aggregated to arrive at one reported value (weight and height will becombined to report BMI in kg/m^2).
4 weeks
Measurement of body weight in participants
Time Frame: 4 weeks
Body weight (kg) will be assessed at baseline and after 4 weeks
4 weeks
Measurement of body composition in participants
Time Frame: 4 weeks
lean mass as percent of body weight and fat mass as percent of body weight will be assessed at baseline and after 4 weeks
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • ttps://www.mdpi.com/2073-4395/12/6/1361 Description: Plant-Derived Biostimulants Differentially Modulate Primary and Secondary Metabolites and Improvethe Yield Potential of Red and Green Lettuce Cultivars

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2023

Primary Completion (Actual)

July 10, 2023

Study Completion (Actual)

September 10, 2023

Study Registration Dates

First Submitted

October 19, 2024

First Submitted That Met QC Criteria

October 22, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

October 24, 2024

Last Update Submitted That Met QC Criteria

October 22, 2024

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • SwE4WEEKS23

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Because is forbidden by the Italian Low

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glucose Metabolism Disorders

Clinical Trials on Biostimulated lettuce supplementation

Subscribe